Title

EYLEA^® blocks VEGF-A and PGF, proteins that play an important role in making the abnormal blood vessels that contribute to the progression of DME. EYLEA^® has been shown to help improve vision or slow vision loss as well as the ability to perform related activities (e.g., reading, driving, etc.).

Approximately 5–8 treatments in the first year: Once a month for the first five months then you may be given injections once every two months.

The eye is disinfected and numbed and then the drug is injected into the eye.

Very common side effects:Bloodshot eye. Common side effects: Decreased sharpness of vision, clouding of the lens, damage to the front layer of the eye, increase in eye pressure, blurred vision, moving spots in vision, detachment of the gel like substance inside the eye (vitreous) from the retina, a feeling of having something in the eye, increased tear production, swelling of the eyelid, eye pain, pain or bleeding at the injection site, redness of the eye and swelling of the front layer of the eyeball.

A solution that is injected into the eye (intravitreal injection).

LUCENTIS^® blocks VEGF-A, a protein that plays an important role in making the abnormal blood vessels that contribute to the progression of DME. LUCENTIS^® has been shown to slow down the progression of vision loss and help improve vision as well as the ability to perform related activities (e.g., reading, driving, etc.).

Approximately 12 treatments in the first year: Once a month. Depending on how you respond to treatment, your doctor will decide if treatment should be stopped.

The eye is disinfected and numbed and then the drug is injected into the eye.

Very common side effects in the eye:Bloodshot eye, eye pain, small particles or spots in your vision, increased pressure inside the eye, displacement of the jelly-like portion inside the eye (vitreous body), swelling of the eye, blurred vision, eye irritation, clouding of the lens, a feeling of having something in the eye, visual disturbance, swelling or infection of the eyelid margin, formation of fibrous tissue under the retina, redness of the eye, blurred or decreased sharpness of vision, dry eye, inflammation of the jelly-like portion inside the eye, temporary blindness, increased tear production, itching of the eye, detachment of a layer of the retina. Common side effects in the eye:Discomfort of the eye, clouding of a part of the lens, deposits in the back of the eye, infection of the surface of the eye, changes in the part of the retina responsible for central vision, bleeding in the back of the eye, degeneration of the retina, small scratches on the cornea (front part of the eye), bleeding in the eye or at the site of injection, tear or detachment of the retina, redness of the eye, light sensitivity, swelling of the eyelid, eyelid pain, eye discharge and bleeding in the jelly-like portion inside the eye.

A laser used to try to seal leaky blood vessels in the eye.

A laser is used to create small burns in areas of the retina where abnormal blood vessels have formed to try to seal the leaks.

Approximately 1–2 treatments: The procedure is usually completed in one session but further treatment may be needed. If you require laser treatment to both eyes, they will be treated one at a time, usually several weeks apart.

The pupil is dilated, the eye is numbed and then laser is applied to the eye.

With this procedure, some side vision may be lost in order to safeguard central vision and scarring of the macula and additional vision loss may occur.

A small implant given by injection into the back of the eye. It can only be used if you have already had an operation for cataract.

By reducing swelling of the macula, the steroid helps to lessen or prevent more damage to the macula. It also reduces the inflammation of the back of the eye.

Approximately 1–2 treatments: No more than two consecutive injections of an implant should be used and an interval of approximately 6 months should be allowed between the two injections.

The eye is disinfected and numbed and then the drug implant is injected into the eye.

Very common side effects:Increased pressure in the eye, clouding of the lens (cataract) and bleeding on the surface of the eye.* Common side effects:High pressure in the eye, bleeding into the inside of the eye*, vitreous detachment, a feeling of spots in front of the eye (including 'floaters')*, a feeling of looking through mist or fog*, eye pain and swelling on the surface of the eye*. *Some of these side effects may be caused by the injection procedure and not the OZURDEX^® implant itself.